Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesDurable Medical Equipment (DME)MVP Health Care Enteral Therapy Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentMVP Health CarePolicy N/A

    Medicare Part B: Enteral Therapy

    Customize your policy alerts

    Sign up for all MVP Health Care policy alerts

    Know when MVP Health Care releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage and prior authorization for enteral nutrition, modified solid foods, medical foods, and related enteral therapy for MVP Health Care Medicare members, including additional criteria for DSNP members in MAP plans.

    Policy Summary
    PayerMVP Health Care
    PolicyMedicare Part B: Enteral Therapy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJun 1, 2026
    Next Review DateN/A
    Key ActionSubmit enteral nutrition requests for review under Medicare LCD L38955 and Policy Article A58833.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    12 monthsMaximum approval duration
    2Medicare coverage references
    EPIQualifying diagnosis for enzyme cartridges

    Coverage Criteria

    Standard Medicare Enteral Nutrition

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Covered under the Prosthetic Device benefit when the applicable Medicare guidance is met.

    ALL of the following

    • Enteral nutrition coverage meets the Medicare Local Coverage Determination (LCD) for Enteral Nutrition (L38955) and the related Policy Article (A58833).

      Refer to LCD L38955 and Policy Article A58833 for applicable coverage requirements.

    In-line Digestive Enzyme Cartridges

    In-line digestive enzyme cartridges are covered when reasonable and necessary for the management of Medicare beneficiaries with exocrine pancreatic insufficiency.

    ALL of the following

    • The member is a Medicare beneficiary with a diagnosis of exocrine pancreatic insufficiency (EPI).
    • Use of the in-line digestive enzyme cartridge, such as RELiZORB, is needed to maintain weight and strength corresponding with the member's overall health status.

      Refer to LCD L38955 for applicable coverage requirements.

    DSNP Variation for MAP Plans

    For MAP plans only, enteral nutrition for DSNP members is covered when Medicare enteral nutrition criteria are met or when one of the following additional DSNP conditions applies.

    ONE of the following

    • The enteral nutrition meets the applicable Medicare enteral nutrition coverage criteria under LCD L38955 and Policy Article A58833.
    • The individual is tube-fed, cannot chew or swallow food, and must obtain nutrition through formula administered by tube.
    • The individual has a rare inborn metabolic disorder requiring a specific medical formula to provide essential nutrients not available through any other means; coverage includes, for certain inherited diseases of amino acid and organic acid metabolism, modified solid food products that are low-protein or contain modified protein.

    Supplemental nutritional therapy, including modified solid foods, medical foods, nutritional supplements, and enteral products administered orally, or products that do not meet the Medicare definition of enteral therapy, are not covered under Medicare Part B or Medicare Part D.

    Initial and continuation approval duration for covered enteral nutrition is up to 12 months.

    Medicare References

    Referenced Medicare LCD and Policy Articlemixed
    L38955Local Coverage Determination for Enteral Nutrition
    A58833Enteral Nutrition - Policy Article

    Provider Action and Review Guidance

    Prior Authorization

    Use Medicare enteral nutrition coverage guidance

    Submit enteral nutrition requests for review under Medicare LCD L38955 and the related Policy Article A58833. Initial and continuation approvals may be issued for up to 12 months.

    • Use Medicare LCD L38955: Local Coverage Determination for Enteral Nutrition.
    • Use Policy Article A58833: Enteral Nutrition - Policy Article.
    • Initial and continuation approval duration is up to 12 months.
    Prior Authorization

    Apply DSNP variation when applicable

    For DSNP members in MAP plans, establish that the request meets the applicable Medicare enteral nutrition criteria or one of the specified DSNP conditions before requesting approval.

    • The member cannot chew or swallow food and must obtain nutrition through formula via tube.
    • The member has a rare inborn metabolic disorder requiring a specific medical formula to provide essential nutrients not available through any other means.
    • For certain inherited amino acid and organic acid metabolism disorders, qualifying modified solid foods may include low-protein or modified-protein products.
    Denial Risk

    Does not meet Medicare enteral therapy definition

    Coverage is denied when supplemental nutritional therapy, including modified solid foods, medical foods, nutritional supplements, or enteral products administered orally, does not meet the Medicare definition of enteral therapy.

    • These services and products are not covered under Medicare Part B or Medicare Part D when they do not meet the Medicare definition of enteral therapy.
    Denial Risk

    Enzyme cartridge criteria not met

    Coverage of in-line digestive enzyme cartridges requires a diagnosis of exocrine pancreatic insufficiency (EPI) and must be reasonable and necessary to maintain the beneficiary's weight and strength consistent with overall health status.

    • Confirm the diagnosis of EPI.
    • Document that cartridge use is needed to maintain weight and strength consistent with overall health status.
    • Refer to LCD L38955 for applicable coverage guidance.

    Background

    Enteral nutrition delivers nutrients into the digestive system as a liquid. It may be administered orally or through a feeding tube, and enteral products may be supplied as liquids or powders reconstituted into liquid form. This policy addresses enteral nutrition and selected in-line digestive enzyme cartridges under Medicare Part B.

    Key Definitions

    Enteral nutrition
    DefinitionNutrition delivered into the digestive system as a liquid.
    Delivery routeMay be provided orally or through a feeding tube.
    Product formsProducts may be liquids or powders reconstituted to a liquid form.
    Exocrine pancreatic insufficiency (EPI)
    AbbreviationEPI
    ConditionExocrine pancreatic insufficiency.
    Relevant coverageIn-line digestive enzyme cartridges may be considered reasonable and necessary for Medicare beneficiaries with EPI to maintain weight and strength corresponding with their overall health status.

    Medical Necessity Criteria

    Medicare Enteral Nutrition Criteria

    Covered under the Prosthetic Device benefit when Medicare enteral nutrition requirements are satisfied.

    Enteral nutrition medical necessity: The enteral nutrition request satisfies the requirements in Medicare LCD L38955 and the related Policy Article A58833.

    In-line Digestive Enzyme Cartridges

    In-line digestive enzyme cartridges must be reasonable and necessary for the management of EPI.

    Digestive enzyme cartridge medical necessity

    • The beneficiary has a diagnosis of exocrine pancreatic insufficiency (EPI).
    • Use of the cartridges is needed to maintain the beneficiary's weight and strength corresponding with the beneficiary's overall health status.

    Not Covered

    Supplemental nutritional therapy, including modified solid foods, medical foods, nutritional supplements, and enteral products administered orally, is not covered under Medicare Part B or Medicare Part D when it does not meet the Medicare definition of enteral therapy.

    Policy Summary
    PayerMVP Health Care
    PolicyMedicare Part B: Enteral Therapy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJun 1, 2026
    Next Review DateN/A
    Key ActionSubmit enteral nutrition requests for review under Medicare LCD L38955 and Policy Article A58833.
    SourceLink
    On This Page
    Coverage CriteriaMedicare ReferencesProvider Action and Review GuidanceBackgroundKey DefinitionsMedical Necessity CriteriaNot Covered